AML and CLL results. Special-Interest session
Over 140 valued HARMONY Alliance community members joined
HARMONY participates in IMI Impact on Patient Involvement event ...
HARMONY Alliance develops Core Outcome Sets for blood cancers. ...
HARMONY wishes you all the best for 2021
HARMONY
Healthcare Alliance for Resourceful Medicine Offensive against Neoplasms in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).